Caspase-8-mediated CYLD Cleavage boosts LPS-induced Endotoxic Shock

Jianling Liu,Ming Li,Mingyan Xing,Han Liu,Xiaoxia Wu,Lingxia Wang,XiaoMing Li,Xiaoming Zhao,Yangjing Ou,Yue Zhang,Fang Li,Qun Xie,Yongchang Tan,YangYang Wang,YangYang Xie,Hanwen Zhang,Hong Li,Yu Li,Yan Luo,Haibing Zhang
DOI: https://doi.org/10.1101/2024.04.03.587858
2024-04-04
Abstract:Caspase-8, a pivotal protease intricately involved in various cellular signaling pathways related to cell death and inflammation, has been identified as a contributor to cytokine production during septic shock. However, the mechanisms governing this regulatory role remain enigmatic. In this study, we uncovered that mice harboring a specific mutation in CYLD at its D215 position ( mutant mice), rendering CYLD resistant to caspase8 cleavage, exhibited marked protection against lethal endotoxic shock. Moreover, the removal of in mice restored their sensitivity to endotoxic shock, indicating Caspase8 promotes LPS-induced endotoxic shock by cleaving its substrate CYLD and maintaining CYLD stability confers resistance to endotoxic shock. Mechanistically, CYLD was found to catalyze the removal of LUBAC-mediated M1-linked ubiquitination of NF-kB p65 at K301/K303, thereby suppressing the nuclear translocation and activation of p65 for subsequent cytokines production. Notably, the cleaved N-terminal fragment of CYLD (named CP25) is secreted in a TRIF/Caspase8-dependent manner. Moreover, CP25 can be detected in the serum of septic mice, and its levels show a strong correlation with corresponding serum IL-1β, suggesting its potential utility as an inflammatory biomarker. Overall, these findings highlight the significance of CYLD cleavage as a promising therapeutic target and diagnostic marker for endotoxic shock.
Immunology
What problem does this paper attempt to address?